This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Innovative Health files reply in support of reviving US tying claims against Biosense

( February 27, 2023, 22:31 GMT | Official Statement) -- MLex Summary: Innovative Health told a US appeals court that rather than addressing the core issues under current tying law, Biosense seeks to affirm a dismissal order based on radical revisions to antitrust doctrine. Innovative argued that ruling in favor of Biosense would allow it to continue to inflate the costs of cardiac procedures, depriving countless patients across our nation of access to life-saving medical care.See document below. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections